Nvidia Pullback Hits AI Complex
Nvidia shares fell nearly 2% midday, giving back earlier gains despite fiscal Q3 results and Q4 revenue guidance that topped expectations. The reversal pressured a wider group of AI-linked names as traders took profits after a strong run:
- Palantir (PLTR): down nearly 6%
- AMD (AMD): lower by about 5%
- Super Micro Computer (SMCI): also off roughly 5%
The move underscores how tightly AI sentiment is tied to Nvidia’s tape: when the market leader stumbles, second-tier beneficiaries often see amplified downside.
Exact Sciences Pops on Abbott Buyout
Exact Sciences (EXAS) jumped about 17% after Abbott Laboratories (ABT) agreed to acquire the Cologuard maker for $105 per share in cash, valuing the deal at roughly $21 billion and targeting a close in Q2 2026.
Abbott shares edged about 1% lower on the announcement, a typical reaction for acquirers absorbing a large cash outlay.
The deal reinforces the premium still available for high-growth, diagnostics-driven platforms in healthcare — even as broader markets debate stretched valuations elsewhere.
Crypto Proxy Names Slide With Bitcoin
Crypto-exposed stocks extended declines as bitcoin’s latest leg down and fading rate-cut expectations weighed on risk sentiment:
- Strategy: down nearly 7%
- Robinhood (HOOD): off about 9%
- Coinbase (COIN): down 7%
- Circle Internet: lower by nearly 6%
ETF outflows, tighter liquidity and macro uncertainty are adding pressure to listed crypto proxies, even as spot prices remain elevated versus prior cycles.
Other Notable Midday Movers
- Regeneron (REGN): up around 4% after US regulators approved Eylea HD for macular edema following retinal vein occlusion.
- Walmart (WMT): up nearly 6% after beating Q3 earnings and revenue expectations and raising full-year sales guidance.
- Palo Alto Networks (PANW): down more than 6% as its $3.35 billion Chronosphere acquisition overshadowed a solid fiscal Q1 beat.
- Oddity (ODD): up 11% after topping Q3 estimates and lifting its full-year earnings outlook.
- Jacobs Solutions (J): down about 9% despite beating Q4 estimates and issuing better-than-expected 2026 guidance.
- Solventum: up roughly 4% on a $725 million cash deal to acquire Acera Surgical and expand into regenerative wound care.
- Bath & Body Works (BBWI): down more than 25% after missing on Q3 earnings and revenue.
WSA Take
Midday action shows a familiar pattern: single-stock catalysts are moving names hard, but the market’s bigger question is still whether AI-linked valuations can sustain another leg higher. Nvidia’s post-earnings wobble is enough to cool the entire complex, while the Exact Sciences buyout highlights that M&A appetite in healthcare remains very real when growth and defensibility line up.
For traders, this is still a tape defined by factor swings: AI winners, crypto proxies and consumer names are all getting repriced day-to-day as rate-cut odds, earnings quality and deal headlines collide.
Read our recent coverage on the Nvidia earnings setup and bitcoin’s renewed sell-off.
Explore more market insights on the Wall Street Access homepage.
Disclaimer:
Wall Street Access does not work with or receive compensation from any public companies mentioned. Content is for informational and educational purposes only and is not investment advice.
